User profiles for P. Landais
 | Paul LandaisMontpellier University Faculty of Medicine Verified email at umontpellier.fr Cited by 22581 |
Treatment of chronic granulomatous disease with myeloablative conditioning and an unmodified hemopoietic allograft: a survey of the European experience, 1985 …
…, P Di Bartolomeo, T Flood, P Landais… - Blood, The Journal …, 2002 - ashpublications.org
Treatment of chronic granulomatous disease (CGD) with myeloablative bone marrow
transplantation is considered risky. This study investigated complications and survival according to …
transplantation is considered risky. This study investigated complications and survival according to …
Organic geochemistry of sedimentary uranium ore deposits
P Landais - Ore Geology Reviews, 1996 - Elsevier
In many sedimentary uranium deposits, close relationships between uranium and organic
matter can be observed. They may be statistical, spatial or chemical. Such relationships entitle …
matter can be observed. They may be statistical, spatial or chemical. Such relationships entitle …
[HTML][HTML] Recommendations for improving the quality of rare disease registries
Rare diseases (RD) patient registries are powerful instruments that help develop clinical
research, facilitate the planning of appropriate clinical trials, improve patient care, and support …
research, facilitate the planning of appropriate clinical trials, improve patient care, and support …
Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease: a meta-analysis of patient-level data
…, A Himmelmann, K Bannister, P Landais… - Annals of internal …, 2001 - acpjournals.org
… were associated with greater risks for ESRD (P < 0.001 and P = 0.002, respectively) and
doubling of baseline serum creatinine or ESRD (P < 0.001 and P < 0.001, respectively). After …
doubling of baseline serum creatinine or ESRD (P < 0.001 and P < 0.001, respectively). After …
Acute renal failure in intensive care units--causes, outcome, and prognostic factors of hospital mortality: a prospective, multicenter study
…, DJ Kleinknecht, P Loirat, PJM Landais - Critical care …, 1996 - journals.lww.com
… The two-tailed significance level was set at p less than .05. … However, each score
appeared significantly different in survivors compared with nonsurvivors either in the group …
appeared significantly different in survivors compared with nonsurvivors either in the group …
Continuous venovenous haemodiafiltration versus intermittent haemodialysis for acute renal failure in patients with multiple-organ dysfunction syndrome: a multicentre …
… , C Camus, A Combes, MA Costa de Beauregard, K Klouche, T Boulain, JD Chiche, P Taupin
… P Taupin and P Landais were involved in the statistical analysis. All authors participated in …
… P Taupin and P Landais were involved in the statistical analysis. All authors participated in …
Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968–99
… over time in survival after both HLA-identical (p=0·04) and nonidentical (p=0·0007) stem-cell …
P Landais and A Fischer contributed equally to coordination of study design, data analysis …
P Landais and A Fischer contributed equally to coordination of study design, data analysis …
A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic …
…, J Banchereau, JM Treluyer, P Landais… - Annals of the …, 2011 - ard.bmj.com
… At M1, 8/12 responders were receiving anakinra and 1 responder receiving placebo (p=0.003).
Ten patients from the placebo group switched to anakinra; nine were responders at M2. …
Ten patients from the placebo group switched to anakinra; nine were responders at M2. …
Prognostic factors in acute renal failure due to sepsis. Results of a prospective multicentre study
… (P<0.001), and in those treated by continuous compared to intermittent techniques (P<0.01). …
membranes had a lower mortality than those treated with cellulose membranes (P<0.005). …
membranes had a lower mortality than those treated with cellulose membranes (P<0.005). …
Transplantation of hematopoietic stem cells and long-term survival for primary immunodeficiencies in Europe: entering a new century, do we do better?
…, A Fischer, M Cavazzana-Calvo, P Landais - Journal of allergy and …, 2010 - Elsevier
BACKGROUND: Hematopoietic stem cell transplantation remains the only treatment for
most patients with severe combined immunodeficiencies (SCIDs) or other primary …
most patients with severe combined immunodeficiencies (SCIDs) or other primary …